Showing results (221-230 of 478) with videos related to

Sort By:
Pageof 48
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2005
Histamine H4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte-derived dendritic cellsRalf Gutzmer, Carola Diestel, Susanne Mommert, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|July 24, 2012
Overdose of the histamine H₃ inverse agonist pitolisant increases thermal pain thresholdsDong Dong Zhang, Marco Sisignano, Claus Dieter Schuh, et al.
British Journal of Clinical Pharmacology|March 21, 2019
Coadministration of the prostaglandin F2α receptor antagonist preterm labour drug candidate OBE022 with magnesium sulfate, atosiban, nifedipine and betamethasoneOliver Pohl, Line Marchand, Jean-Pierre Gotteland, et al.
British Journal of Clinical Pharmacology|December 14, 2021
A model-based analysis to guide gonadotropin-releasing hormone receptor antagonist use for management of endometriosisOliver Pohl, Kyle Baron, Matthew Riggs, et al.
Current Drug Safety|May 10, 2013
Carcinogenicity and chronic rodent toxicity of the selective progesterone receptor modulator ulipristal acetateOliver Pohl, Philip W Harvey, Sean McKeag, et al.
British Journal of Clinical Pharmacology|May 1, 2018
Pharmacokinetics, safety and tolerability of OBE022, a selective prostaglandin F2α receptor antagonist tocolytic: A first-in-human trial in healthy postmenopausal womenOliver Pohl, Line Marchand, Jean-Pierre Gotteland, et al.
Molecules (Basel, Switzerland)|September 10, 2021
ST-2191, an Anellated Bismorpholino Derivative of Oxy-Fingolimod, Shows Selective S1P1 Agonist and Functional Antagonist Potency In Vitro and In VivoBisera Stepanovska Tanturovska, Aleksandra Zivkovic, Faik Imeri, et al.
Chemmedchem|March 17, 2007
Highly potent fluorescence-tagged nonimidazole histamine H3 receptor ligandsMichael Amon, Xavier Ligneau, Jean-Claude Camelin, et al.
Bioorganic Chemistry|January 10, 2020
4-(4-Chlorophenyl)thiazol-2-amines as pioneers of potential neurodegenerative therapeutics with anti-inflammatory properties based on dual DNase I and 5-LO inhibitionAndrija Smelcerovic, Aleksandra Zivkovic, Budimir S Ilic, et al.
Current Pharmaceutical Design|February 1, 2020
Experimental Models for the Discovery of Novel Anticonvulsant Drugs: Focus on Pentylenetetrazole-Induced Seizures and Associated Memory DeficitsAlaa Alachkar, Shreesh K Ojha, Adel Sadeq, et al.
Pageof 48